These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 575431)

  • 21. Myasthenia gravis after botulinum toxin A for Meige syndrome.
    Tarsy D; Bhattacharyya N; Borodic G
    Mov Disord; 2000 Jul; 15(4):736-8. PubMed ID: 10928589
    [No Abstract]   [Full Text] [Related]  

  • 22. [Myasthenic syndrome induced by D-penicillamine. Danger of curarization].
    Blanloeil Y; Baron D; Nicolas F
    Nouv Presse Med; 1980 Dec; 9(48):3695-6. PubMed ID: 6450409
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myasthenic syndrome during treatment with D penicillamine. A recent case].
    Verret JM; Lignac N; Kahn MF
    Ann Med Interne (Paris); 1977; 128(6-7):557-60. PubMed ID: 921113
    [No Abstract]   [Full Text] [Related]  

  • 24. Iatrogenically revealed myasthenia gravis.
    Gyawali P; Rangedara DC
    Int J Clin Pract; 1999 Dec; 53(8):645. PubMed ID: 10692763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not only ineffective, but also potentially dangerous. Therapy with "universal specific remedies"].
    Hakimi R
    MMW Fortschr Med; 2002 Dec; 144(50):49-51. PubMed ID: 14610866
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prognostic factors of myasthenic crisis after extended thymectomy in patients with generalized myasthenia gravis].
    Liu WB; Men LN; Tang BY; Huang RX
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2737-40. PubMed ID: 17199991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myasthenic syndrome following oral treatment with penicillamine].
    François J; Verbraeken H; Gabriel P; Wille C
    Bull Soc Belge Ophtalmol; 1978; 182():126-30. PubMed ID: 756327
    [No Abstract]   [Full Text] [Related]  

  • 28. Myasthenic syndrome associated with antibiotics.
    McQuillen MP; Cantor HA; O'Rourke JR
    Trans Am Neurol Assoc; 1967; 92():163-7. PubMed ID: 4329412
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myasthenic syndrome following long-term diphenylhydantoin therapy].
    Milonas J; Kountouris D; Scheer E
    Nervenarzt; 1983 Aug; 54(8):437-8. PubMed ID: 6413870
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of myasthenia gravis associated with long-term phenytoin therapy].
    Ozawa T; Nakajima T; Furui E; Fukuhara N
    Rinsho Shinkeigaku; 1996 Nov; 36(11):1262-4. PubMed ID: 9046861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myasthenic syndrome induced by D-penicillamine. Changes in serum levels of acetylcholine receptor antibodies].
    Woimant F; Benacin L; Delauche MC; Haguenau M; Pepin B
    Nouv Presse Med; 1982 May; 11(23):1807-8. PubMed ID: 7099959
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myasthenia gravis syndrome following administration of d-penicillamine (author's transl)].
    Rousseau JJ; Dieudonne LG
    Acta Neurol Belg; 1980; 80(3):165-73. PubMed ID: 7457085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Our observations regarding the treatment of multiple sclerosis with TFX "Polfa"].
    Fryze W; Obiedziński R
    Neurol Neurochir Pol; 1988; 22(5):475. PubMed ID: 3249619
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myasthenia with Sjogren's syndrome and thymoma - clinical evaluation of myasthenic syndrome].
    Saito M; Hirayama K; Narabayashi H
    Rinsho Shinkeigaku; 1975 Nov; 15(11):811-6. PubMed ID: 1241353
    [No Abstract]   [Full Text] [Related]  

  • 35. [A myasthenic episode following intake of large amounts of a beta blocker].
    Kómár J; Szalay M; Szél I
    Fortschr Neurol Psychiatr; 1987 Jun; 55(6):201-2. PubMed ID: 3610012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electromyographic and morphological analysis of the changes in the motor units in myasthenia, combined myasthenia with thymoma and polymyositis and terminal polyneuropathy with myasthenic syndrome].
    Gekht BM; Gustaĭnis VV; Kasatkina LF; Nikitin SS; Nozdracheva LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1624-32. PubMed ID: 7324663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neonatal myasthenia gravis].
    Belasco C; Carbillon L; Louaib D; Gaudelus J; Uzan M
    Arch Pediatr; 2000 Mar; 7(3):263-6. PubMed ID: 10761602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis-like syndrome induced by topical ophthalmic preparations. A case report.
    Meyer D; Hamilton RC; Gimbel HV
    J Clin Neuroophthalmol; 1992 Sep; 12(3):210-2. PubMed ID: 1401170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-penicillamine and the ocular myasthenic syndrome.
    Kimbrough RL; Mewis L; Stewart RH
    Ann Ophthalmol; 1981 Oct; 13(10):1171-2. PubMed ID: 7316342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis.
    Oh SJ; Cho HK
    Muscle Nerve; 1990 Mar; 13(3):187-91. PubMed ID: 2320039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.